Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has given tentative approval to Lupin Pharmaceuticals' (LPI) Pregabalin capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg.
Subscribe to our email newsletter
The Pregabalin capsules are the generic version of Lyrica capsules of CP Pharmaceuticals.
Lyrica (Pregabalin) capsules are indicated as a treatment of neuropathic pain linked with diabetic peripheral neuropathy, post herpetic neuralgia, adjunctive therapy for adult patients with partial onset seizures and fibromyalgia.